Finally, patients in the p53abn group showed a trend toward improved survival with higher BMI cutoffs (3‐year survival: BMI, <25, 70.7%; BMI, >35, 85.2%; data not shown).
← all excerpts
The impact of the patient macroenvironment on molecular subgroups in endometrial cancer.
1
—
—